StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
This year
3
Publishing Date
2024 - 03 - 11
1
2024 - 02 - 01
1
2024 - 01 - 31
1
2023 - 11 - 01
1
2023 - 10 - 12
1
2023 - 10 - 09
1
2023 - 06 - 12
1
2023 - 06 - 09
1
2023 - 03 - 16
1
2023 - 02 - 19
1
2022 - 09 - 20
1
2022 - 09 - 15
1
2022 - 08 - 18
1
2022 - 06 - 27
1
2022 - 06 - 24
1
2022 - 06 - 23
1
2022 - 06 - 20
1
2022 - 06 - 17
1
2022 - 04 - 26
1
2022 - 03 - 31
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 02 - 07
1
2021 - 12 - 16
1
2021 - 10 - 08
1
2021 - 09 - 21
1
Sector
Health technology
26
Manufacturing
26
Tags
Acquisition
4
Advanced
5
Agreement
19
Alliances
6
America
15
Antibody
6
Application
18
Approved
5
Asco
4
Asia
7
At845
5
Authorization
5
Biotech
7
Biotech-bay
7
Bladder
12
Cancer
49
Cell
7
Children
4
China
4
Chmp
4
Collaboration
15
Companies
12
Cresemba
4
Disease
16
Drug
26
Earnings
4
Events
5
Expected
4
Fda
17
Financial
4
Genetown
5
Global
27
Grants
4
Growing
6
Growth
47
Health
4
Japan
7
Leukemia
6
License
17
Management
7
Market
113
N/a
269
Padcev
11
Pharma
13
Pharmaceutical
5
Positive
14
Reach
5
Report
24
Research
43
Results
19
Set
5
Study
14
Therapeutics
35
Therapy
23
Topline
10
Treatment
50
Trial
22
Update
6
Vaccine
7
Xtandi
6
Entities
Abbott laboratories
3
Abbvie inc.
3
Abeona therapeutics inc.
2
Adaptimmune therapeutics plc
2
Adc therapeutics sa
1
Amgen inc.
4
Ardelyx, inc.
1
Astellas pharma inc
26
Astrazeneca plc
4
Biogen inc.
3
Eli lilly and company
2
Endo international plc
1
Exelixis, inc.
1
Galmed pharmaceuticals ltd.
1
Generation bio co.
2
Gilead sciences, inc.
1
Glaxosmithkline plc
5
Immunogen, inc.
1
Ionis pharmaceuticals, inc.
1
Ironwood pharmaceuticals, inc.
1
Jazz pharmaceuticals plc
1
Johnson & johnson
2
Kempharm inc
1
Novartis ag
9
Orchard therapeutics plc
2
Pfizer, inc.
2
Sanofi
6
Sutro biopharma, inc.
2
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
3
Thermo fisher scientific inc
1
Viatris inc.
2
Zymeworks inc.
1
Symbols
ABBV
75
ABT
64
ALGS
17
ALNY
11
ALPMF
26
ALPMY
26
AMGN
54
ARDX
11
ARQT
11
ARVL
11
AZN
69
AZNCF
47
BAX
15
BDX
34
BHC
22
BIIB
28
BIO
12
BMY
63
BSX
13
CERT
11
CRL
13
DHR
14
ENDP
13
ENVB
12
EVOTF
20
FNCTF
27
GILD
25
GLAXF
76
GLPG
12
GSK
109
HOTH
12
IMAB
11
INBS
19
INCY
33
IONS
14
JAGX
33
JNJ
224
LEXX
11
LH
14
LLY
105
LTRN
33
MDT
24
MNKD
12
NNVC
21
NVO
18
NVS
115
NVSEF
85
PFE
54
PRGO
13
SNY
240
SNYNF
173
SRNE
11
STRO
12
TAK
29
TEVJF
44
TMO
48
TNXP
12
VTRS
15
WST
14
ZLAB
11
Exchanges
Nasdaq
26
Nyse
13
Crawled Date
2024 - 03 - 11
1
2024 - 02 - 01
1
2024 - 01 - 31
1
2023 - 11 - 01
1
2023 - 10 - 12
1
2023 - 10 - 09
1
2023 - 06 - 12
1
2023 - 06 - 09
1
2023 - 03 - 16
1
2023 - 02 - 20
1
2022 - 09 - 20
1
2022 - 09 - 15
1
2022 - 08 - 18
1
2022 - 06 - 28
1
2022 - 06 - 24
2
2022 - 06 - 20
1
2022 - 06 - 17
1
2022 - 04 - 26
1
2022 - 03 - 31
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 02 - 07
1
2021 - 12 - 16
1
2021 - 10 - 08
1
2021 - 09 - 21
1
Crawled Time
00:00
3
02:00
3
03:00
1
04:00
1
07:00
1
08:00
1
09:00
3
10:00
1
13:00
1
14:00
3
14:30
1
15:00
1
15:20
1
15:30
1
16:00
1
18:00
2
19:00
1
Source
www.biospace.com
2
www.globenewswire.com
1
www.prnewswire.com
23
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Drug
symbols :
Alpmf
save search
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Published:
2024-03-11
(Crawled : 13:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-12.05%
|
O:
-1.41%
H:
5.06%
C:
4.01%
cresemba
fda
drug
children
grants
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
Published:
2024-02-01
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-19.48%
|
O:
-0.86%
H:
3.34%
C:
0.43%
drug
pipeline
series
extension
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer
Published:
2024-01-31
(Crawled : 02:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-16.94%
|
O:
4.34%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-19.27%
|
O:
0.0%
H:
1.38%
C:
0.26%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-5.92%
|
O:
0.56%
H:
1.25%
C:
-0.33%
keytruda
drug
japan
bladder
cancer
treatment
application
advanced
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-23.18%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.67
-2.03%
-1.96%
730K
|
Health Technology
|
26.07%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-3.66%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.76
-4.03%
-0.84%
280K
|
Health Technology
|
609.28%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
15.93%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
M
|
$3.77
-0.79%
-1.06%
770K
|
Health Technology
|
47.29%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-16.57%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$22.49
-1.66%
-1.78%
2.1M
|
Health Technology
|
9.54%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Hepatitis C Disease Market: Clinical Trial, Drug Development, Clinical Viewpoints, and Drug Insights| Disease Landscape Insights
Published:
2023-10-12
(Crawled : 14:30)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-31.22%
|
O:
-2.72%
H:
2.65%
C:
2.12%
hepatitis
drug
disease
Reshaping Cystic Fibrosis Disease Landscape Report | Epidemiology Study, Drug Insights, Unmet Needs Analysis, KOL Perspectives Product Launch Services, and Regulatory Consulting |Disease Landscape Insights
Published:
2023-10-09
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-31.47%
|
O:
-0.04%
H:
0.77%
C:
0.7%
drug
disease
report
fibrosis
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published:
2023-06-12
(Crawled : 15:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-42.42%
|
O:
-0.68%
H:
3.23%
C:
1.55%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-7.78%
|
O:
-0.16%
H:
0.11%
C:
-0.76%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
241.48%
|
O:
0.62%
H:
4.57%
C:
2.04%
GBIO
|
$2.78
-6.71%
-7.39%
200K
|
Health Technology
|
-38.43%
|
O:
0.0%
H:
11.57%
C:
6.4%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-36.82%
|
O:
3.52%
H:
0.0%
C:
-1.99%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
21.11%
|
O:
0.22%
H:
0.0%
C:
-0.86%
ADAP
|
$0.8984
-8.98%
-9.86%
48K
|
Health Technology
|
4.31%
|
O:
-0.75%
H:
7.14%
C:
6.12%
ABEO
|
$7.53
-5.04%
-5.03%
250K
|
Health Technology
|
77.18%
|
O:
0.0%
H:
4.4%
C:
3.29%
drug
set
therapy
growth
market
Astellas Submits New Drug Application for Zolbetuximab in Japan
Published:
2023-06-09
(Crawled : 04:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-40.96%
|
O:
0.46%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.99%
|
O:
0.81%
H:
0.0%
C:
-0.06%
drug
japan
application
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published:
2023-03-16
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
39.15%
|
O:
1.16%
H:
0.73%
C:
0.73%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-32.17%
|
O:
0.44%
H:
0.29%
C:
0.29%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
13.37%
|
O:
0.18%
H:
0.77%
C:
0.64%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
219.81%
|
O:
-4.62%
H:
4.44%
C:
-6.05%
GBIO
|
$2.78
-6.71%
-7.39%
200K
|
Health Technology
|
-17.45%
|
O:
-0.55%
H:
6.69%
C:
1.95%
BIIB
|
$190.52
-0.85%
-0.84%
1.3M
|
Health Technology
|
-25.62%
|
O:
-1.11%
H:
2.97%
C:
2.23%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
12.79%
|
O:
-0.49%
H:
0.39%
C:
0.36%
ADAP
|
$0.8984
-8.98%
-9.86%
48K
|
Health Technology
|
-8.85%
|
O:
-2.65%
H:
14.55%
C:
9.09%
ABEO
|
$7.53
-5.04%
-5.03%
250K
|
Health Technology
|
187.4%
|
O:
-2.29%
H:
3.52%
C:
-0.78%
drug
therapy
market
Astellas Provides Update on Fezolinetant New Drug Application in U.S.
Published:
2023-02-19
(Crawled : 00:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
Email alert
Add to watchlist
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
Email alert
Add to watchlist
drug
application
update
Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts
Published:
2022-09-20
(Crawled : 02:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-32.07%
|
O:
-0.51%
H:
0.07%
C:
-0.29%
drug
research
biotech
Worldwide Irritable Bowel Syndrome with Constipation Drugs Industry to 2030 - by Drug Type, Prescription Type and Region
Published:
2022-09-15
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
10.75%
|
O:
1.6%
H:
0.0%
C:
-6.5%
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
16.27%
|
O:
0.97%
H:
0.0%
C:
-3.99%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-32.32%
|
O:
0.22%
H:
0.14%
C:
-0.43%
ABT
|
News
|
$105.27
-0.6%
-0.38%
5.9M
|
Health Technology
|
0.59%
|
O:
0.26%
H:
0.96%
C:
-0.94%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
12.76%
|
O:
0.4%
H:
0.84%
C:
0.37%
IRWD
|
$7.6
-0.65%
-0.79%
27
|
Health Technology
|
-31.22%
|
O:
0.0%
H:
0.72%
C:
-1.27%
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
16.26%
|
O:
-0.19%
H:
0.09%
C:
-0.8%
ARDX
|
News
|
$6.44
-1.68%
-1.63%
2.9M
|
Health Technology
|
366.67%
|
O:
-2.9%
H:
3.73%
C:
2.24%
drug
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Published:
2022-08-18
(Crawled : 07:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-35.18%
|
O:
2.87%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-38.02%
|
O:
-0.8%
H:
0.33%
C:
-0.8%
fda
drug
application
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Published:
2022-06-27
(Crawled : 00:00)
- globenewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-39.39%
|
O:
5.56%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.44%
|
O:
1.88%
H:
0.0%
C:
-0.68%
STRO
M
|
$3.77
-0.79%
-1.06%
770K
|
Health Technology
|
-12.24%
|
O:
15.01%
H:
14.86%
C:
5.02%
collaboration
drug
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published:
2022-06-24
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-39.1%
|
O:
0.99%
H:
0.0%
C:
-0.5%
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
-22.4%
|
O:
3.19%
H:
2.28%
C:
-1.81%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.19%
|
O:
8.01%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
42.6%
|
O:
6.71%
H:
0.0%
C:
-0.1%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.33%
|
O:
4.33%
H:
0.0%
C:
-2.44%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
14.09%
|
O:
2.38%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
-25.89%
|
O:
1.26%
H:
0.95%
C:
0.92%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
11.29%
|
O:
1.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-10.17%
|
O:
3.49%
H:
0.0%
C:
0.0%
GLMD
|
$0.3787
2.8%
-0.41%
27K
|
Health Technology
|
-99.67%
|
O:
1.21%
H:
0.0%
C:
-3.5%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
8.99%
|
O:
0.37%
H:
0.82%
C:
0.56%
europe
growth
market
drug
Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Published:
2022-06-23
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-39.1%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.33%
|
O:
4.33%
H:
0.0%
C:
-2.44%
fda
drug
application
Insights on the Psoriasis Therapeutics Global Market to 2028 - Cumulative Development of New Biologics and New Pipeline Drugs Presents Opportunities
Published:
2022-06-20
(Crawled : 15:20)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$138.24
-1.36%
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
psoriasis
market
drug
ExCellThera announces submission of Drug Master File for UM171
Published:
2022-06-17
(Crawled : 14:00)
- biospace.com/
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-37.32%
|
O:
-1.34%
H:
0.2%
C:
-0.61%
um171
drug
submission
Global Genitourinary Drugs Market Research Report to 2027 - Increasing Prevalence of Genitourinary Disorders is Driving Growth
Published:
2022-04-26
(Crawled : 14:00)
- prnewswire.com
ALPMF
|
$9.17
-4.42%
43.47%
16K
|
Health Technology
|
-37.74%
|
O:
2.56%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.15%
|
O:
0.13%
H:
0.06%
C:
-0.69%
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-46.84%
|
O:
3.08%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
3.61%
|
O:
0.47%
H:
0.83%
C:
-1.44%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-20.62%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
163.24%
|
O:
0.34%
H:
1.41%
C:
-1.17%
IONS
|
$40.81
-0.24%
-0.25%
990K
|
Health Technology
|
-3.61%
|
O:
-0.12%
H:
0.07%
C:
-5.13%
research
report
growth
market
drug
GHIT Fund Announces New Investments: A Total of 740 Million Yen for Malaria Drugs and Vaccine
Published:
2022-03-31
(Crawled : 03:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-41.29%
|
O:
-0.69%
H:
0.0%
C:
-1.39%
vaccine
drug
malaria
← Previous
1
2
Next →
Gainers vs Losers
59%
41%
Top 10 Gainers
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
TPET
|
$0.3279
-3.56%
28.48%
33M
|
n/a
GDHG
|
$0.263
21.76%
25.34%
1.3M
|
HOLO
|
$2.95
31.7%
22.49%
37M
|
UMAC
|
$1.55
0.65%
16.13%
3K
|
MTNB
|
$0.19
-1.04%
14.58%
950K
|
Health Technology
VLD
4
|
$0.2638
-3.65%
13.27%
2.6M
|
Manufacturing
TAOP
|
$1.08
13.01%
11.51%
19K
|
Technology Services
MGLD
4
|
$1.13
5.61%
10.62%
200
|
Manufacturing
NURO
|
$3.65
2.24%
10.3%
3.9K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.